🇺🇸 FDA
Company

Pyxis

Pyxis Oncology

PYXS pharma USA

Quick answer

Pyxis is a pharma company (PYXS) headquartered in BOSTON, MA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

APX005M

Melanoma

Phase 2 · small_molecule · terminated

1 trials project

PYX-201

Advanced Solid Tumors

Phase 2 · small_molecule · active

1 trials project

APX005M treatment for recurrent or refractory primary malignant CNS tumor patients

Glioblastoma Multiforme

Phase 1 · mab · active

1 trials project

PYX-106

Solid Tumor

Phase 1 · small_molecule · active

1 trials project

PYX-201

Solid Tumor

Phase 1 · small_molecule · active

1 trials

Patents (3)

patent

US 10675324

Compositions and methods for modulating AT2R activity

Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10105411

Compositions and methods for modulating AT2R activity

Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9700686

Fluid delivery devices and methods

Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)